NEW

The Joint Commission, Joint Commission Resources Launch Data Transparency Initiative

The Joint Commission and Joint Commission Resources (JCR) Inc. have announced a new data transparency initiative – Data Analytics for Safe Healthcare (DASH).

Aerobiotix Announces FDA 510(k) Clearance of Medical Ultraviolet Air Filtration System

Aerobiotix Inc., a manufacturer of air treatment devices for hospitals and health care, has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Aerocure-MD medical air purification system.

AAAHC Releases Updated Toolkit Outlining Ambulatory Procedure Considerations for Obese Patients

To help ASCs implement necessary precautions and prevent negative outcomes for obese patients, the Accreditation Association for Ambulatory Health Care (AAAHC) has published a fully revised Ambulatory Procedure Considerations for Obese Patients Toolkit.

FDA Updates Information on Respirator Decontamination Systems

The U.S. Food and Drug Administration (FDA) is reissuing the Emergency Use Authorizations for decontamination systems that are authorized to decontaminate compatible N95 respirators for use by healthcare personnel (HCP) to prevent exposure to pathogenic biological...

COVID-19 Best Practices – Where We Are and Where We Are Heading!

April 9, 2020

  • Fill Out This Form To Watch the Webinar



  • Fill Out This Form To Receive Your Certificate

  • *Please ensure your name is entered correctly as this is how it will appear on your certificate.

This 60-minute webinar will feature Dr. John Kutz, F.A.C.S. Medical Advisor at RepScrubs. Join Dr Kutz as he discusses the big topic COVID-19 best practices. Dr. Kutz discusses what is going on in the frontlines right now and how we can improve protocols for the future.

About the Presenter: Dr. John Kutz, F.A.C.S. Medical Advisor at RepScrubs.

Dr. Kutz, a native of Dallas, Pennsylvania, graduated from The University of Scranton where he studied Biology and Philosophy. He received his Doctorate of Medicine from Sidney Kimmel Medical College, formerly Jefferson Medical College, of Thomas Jefferson University with several honors including AOA, and Excellence in Surgery. Dr. Kutz completed his surgical residency at Thomas Jefferson University Hospital where he was recognized for excellence in resident teaching and research. Following his training at Thomas Jefferson University Hospital, Dr. Kutz served as General Surgeon in the United States Air Force. He then returned to Pennsylvania where he completed a Fellowship in Vascular Surgery at the Pennsylvania Hospital of the University of Pennsylvania.

Dr. Kutz maintains board certification by the American Board of Surgery in both general and vascular surgery. He is a Fellow of the American College of Surgeons and a member of the Society for Vascular Surgery as well as the Society for Clinical Vascular Surgery. After returning to Scranton in 2003, Dr. Kutz established a practice in vascular and endovascular surgery. Currently employed by Commonwealth Health Systems Dr. Kutz was formerly a partner/owner in Delta Medix a multi-specialty group based in Scranton, Pennsylvania. He currently serves as Chairman of the Department of Surgery, Section Chief of Vascular Surgery, Director of the Vascular Laboratory, and Director of the Wound Care Center at Regional Hospital of Scranton, Scranton Pennsylvania.

OR Today would like to thank our sponsor, RepScrubs! RepScrubs offers vendor management and cost reduction solutions. The RepScrubs program provides assurance that every vendor entering a sterile department is wearing clean prepackaged disposable polypropylene scrubs dispensed onsite, while shifting the expense of providing those scrubs back to the vendor. The RepScrubs system offers hospitals a unique way of improving infection prevention and adherence to regulatory guidelines, reducing costs, and enabling hospitals to better control and manage vendor access. For more information visit www.repscrubs.com.

*MD Publishing takes every precaution to ensure accuracy of content; however, the information, opinions, and statements expressed in the webinars and advertisements herein are those of the writer and/or advertiser, and not those of our company.

X